News
Capital Market on MSN10h
Glenmark Pharma receives warning letter from USFDA for Indore facilityThe USFDA inspection was conducted between 3 February and 14 February 2025. In an official filing, the company stated that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback